Jazz Pharmaceuticals (JAZZN) Q3 2020 Earnings Report
MX:JAZZN Q3 2020 EPS Results
- Actual EPS
- MXN 80.08
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 76.18
MX:JAZZN Q3 2020 Revenue Results
- Actual Revenue
- MXN 11.16B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +11.75%
Earnings Announcement Details
- Quarter
- Q3 2020
- Date
- 11/02/2020
- Time
- After Close
- Conference Call
- Monday, November 2, 2020
MX:JAZZN Upcoming Earnings
Jazz Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q3 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:JAZZN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 131.20- | 123.38 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -74.92-72.09 | 151.06 | -147.72% (-223.16) | |
| Aug 03, 2026 | 2026 (Q2) | 114.74106.10 | -153.29 | 169.21% (+259.39) | |
| May 05, 2026 | 2026 (Q1) | 86.23117.80 | 31.22 | 277.38% (+86.59) | |
| Feb 24, 2026 | 2025 (Q4) | 121.11123.38 | 122.63 | 0.61% (+0.74) | |
| Nov 05, 2025 | 2025 (Q3) | 110.48151.06 | 122.82 | 23.00% (+28.24) | |
| Aug 05, 2025 | 2025 (Q2) | -141.33-153.29 | 98.48 | -255.66% (-251.77) | |
| May 06, 2025 | 2025 (Q1) | 86.5531.22 | 49.8 | -37.31% (-18.58) | |
| Feb 25, 2025 | 2024 (Q4) | 108.92122.63 | 93.28 | 31.47% (+29.36) | |
| Nov 06, 2024 | 2024 (Q3) | 102.16122.82 | 89.93 | 36.57% (+32.89) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
